Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16

Summary

This is an open, multi-center, multi-cohort phase I clinical study designed to evaluate safety, tolerability, pharmacokinetics and initial efficacy of FTL008.16 in patients with advanced and metastatic solid tumors.

Timeline

Start

2025-05-27

Primary completion

2026-11

Completion

2027-11

Drugs

Indications